Czibere Akos bought AKTS
July 8, 2026 · Form 4 insider transaction
Czibere Akos bought 50,000 shares of Aktis Oncology, Inc. at $4.95 per share, a transaction worth $247.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
50,000
Price
$4.95
Total value
$247.5K
InsiderCzibere Akos
RoleOfficer
CompanyAktis Oncology, Inc. (AKTS)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 8, 2026
Filing dateJuly 10, 2026
Shares owned after50,000
OwnershipDirect
10b5-1 planNo
AmendedNo